Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2021

May 18, 2021

34129_dirs_2021-05-17_252afab3-088d-4e55-92e2-52694129f0ac.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2021-05-13

Reporting Person: Jackson Scott Thomas (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-13 Stock Option (right to buy) $28.88 A 15000 Acquired 2031-05-13 Common Stock (15000.0) Direct

Footnotes

F1: The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.